Psoriasis Research and Trends

Psoriasis research has accelerated significantly. This article covers the five most active areas — new non-steroidal topicals including the May 2025 roflumilast foam approval, the biologics and biosimilar landscape, the now-documented gut-skin axis mechanisms, natural formulations including coal tar and curcumin, and where AI in dermatology is heading. Evidence-based, evergreen framing with an annual update note.